SCHEMBL25063201

SCHEMBL25063201

CCCC(=O)Nc1cccc(C(=O)OC)c1N

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 9/20 0.56
KMT2A Q03164 3/20 0.55
KDM4E B2RXH2 3/20 0.53
MAPK1 P28482 1/20 0.51
MAPK10 P53779 2/20 0.49
MAPK8 P45983 1/20 0.49
MAPK9 P45984 1/20 0.49
POLB P06746 1/20 0.49
MTNR1B P49286 1/20 0.48
HTT P42858 1/20 0.48
HSD17B10 Q99714 3/20 0.48
BDKRB1 P46663 1/20 0.47
ALOX12 P18054 1/20 0.47
TSHR P16473 1/20 0.47
MEN1 O00255 1/20 0.47
LMNA P02545 1/20 0.47
THRA P10827 1/20 0.47
THRB P10828 1/20 0.47
GAA P10253 1/20 0.47
CYP1A2 P05177 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25063197 0.85 MAPK1 (0.54) ALDH1A1KMT2AKDM4EMAPK1POLB
SCHEMBL15808796 0.84 KDM4E (0.58) ALDH1A1KMT2AKDM4EMAPK10MAPK8
SCHEMBL11956569 0.82 KMT2A (0.54) ALDH1A1KMT2AKDM4EMAPK1MAPK10
SCHEMBL20594648 0.81 ALDH1A1 (0.75) ALDH1A1KMT2AKDM4EMAPK10MAPK8
SCHEMBL1917958 0.80 ALDH1A1 (0.53) ALDH1A1KMT2AKDM4EMTNR1BHSD17B10
SCHEMBL27910331 0.79 MAPK1 (0.57) ALDH1A1KMT2AMAPK1POLBMTNR1B
SCHEMBL20692016 0.77 HSD17B10 (0.55) ALDH1A1KMT2AKDM4EMAPK1POLB
SCHEMBL940016 0.77 KDM4E (0.68) ALDH1A1KMT2AKDM4EMAPK1POLB
SCHEMBL18950889 0.77 HSD17B10 (0.55) ALDH1A1KMT2AKDM4EMAPK1POLB
SCHEMBL825285 0.77 KDM4E (0.55) ALDH1A1KMT2AKDM4EMAPK1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240066136-A1 MODIFIED PROTEINS AND PROTEIN DEGRADERS CULLGEN (SHANGHAI), INC. (CN) 2024-02-29 US disclosed
CN-116472292-A Modified proteins and protein degrading agents 上海睿跃生物科技有限公司 2023-07-21 CN disclosed
US-20230057177-A1 MODIFIED PROTEINS AND PROTEIN DEGRADERS CULLGEN (SHANGHAI), INC. (CN) 2023-02-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240066136-A1 MODIFIED PROTEINS AND PROTEIN DEGRADERS DDB1, DCLRE1A, MDM2 ALDH1A1 1427/4885KMT2A 1342/4885KDM4E 786/4885
US-20230057177-A1 MODIFIED PROTEINS AND PROTEIN DEGRADERS DDB1, DCLRE1A, MDM2 ALDH1A1 1427/4885KMT2A 1342/4885KDM4E 786/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.